adrenergic

(redirected from Alpha adrenergic)
Also found in: Dictionary, Thesaurus, Medical.
Related to Alpha adrenergic: Beta adrenergic

adrenergic

[‚ad·rə′nər·jik]
(physiology)
Describing the chemical activity of epinephrine or epinephrine-like substances.
References in periodicals archive ?
Voiding flow rates in the sitting position were significantly better than in the standing position for symptomatic BPH patients; alpha adrenergic blockers did not eliminate affect the rates between the two positions.
Beginning in March 2000, Synaptic started making available nonexclusive licenses to those companies in need of Synaptic's portfolio of patents on the alpha adrenergic receptors for drug discovery.
Alpha adrenergic receptors are GPCRs that are activated by the neurotransmitter norepinephrine (noradrenaline).
In March of this year, Synaptic began to make available non-exclusive licenses to its alpha adrenergic and BPH patents and technology.
NYSE:AGN) For neuropathic pain, pre-clinical work studying ACADIA's alpha adrenergic agonist compound yielded encouraging data.
ACADIA has several drug discovery programs targeting GPCRs: muscarinic agonists for dementia and glaucoma, alpha adrenergic agonists for glaucoma and neuropsychiatric disease, and serotonin 2A inverse agonists for schizophrenia.
Hicks: There are a number of competitors in this field: Muse, a rigid plastic applicator that deposits a pellet containing prostaglandin approximately 1-1/2 inches into the uretha; Laverject, an injection of prostaglandin directly into the penis by needle; Sildanafil, an orally administered product, for patients without an organic cause for their condition, which is expected to become available in the future; Phentolamine, an orally administered alpha adrenergic blocker, for patients without an organic cause for their condition, which is currently undergoing assessment in clinical trials.
This patent is a nice complement to our marketing program for non exclusive licenses to our alpha adrenergic and BPH technologies.
patent (6,083,705) for the use of the alpha adrenergic 1D receptor to screen compounds that bind to it.
Amex: SHM) today announced the successful completion of a pilot study using Sheffield's Aerosol Drug Delivery System (ADDS) to deliver ergotamine, an alpha adrenergic blocking agent used as a therapy to stop or prevent vascular headaches such as migraine.